State Board of Administration of Florida Retirement System’s AbCellera Biologics ABCL Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio ABCL Stock Details ABCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-52,800	Closed	-$398K	–	2189
2024 Q1	$398K	Buy	+52,800	New	+$269K	﹤0.01%	1641
2023 Q2	–	Sell	-52,800	Closed	-$398K	–	2409
2023 Q1	$398K	Hold	52,800	–	–	﹤0.01%	1699
2022 Q4	$535K	Buy	52,800 +1,420	+3%	+$16.4K	﹤0.01%	1569
2022 Q3	$508K	Hold	51,380	–	–	﹤0.01%	1585
2022 Q2	$547K	Buy	+51,380	New	+$435K	﹤0.01%	1596

Other funds holding ABCL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FFVM

Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Board of Administration of Florida Retirement System's ABCL Position: Q2 2024 in Review

State Board of Administration of Florida Retirement System sold out of AbCellera Biologics (ABCL) in Q2 2024, closing a stake of 52,800 shares — an estimated $398K sold.

State Board of Administration of Florida Retirement System first reported a position in ABCL in Q2 2022 and held it in 5 quarters. The position peaked at $547K in Q2 2022. 146 funds tracked by Wall St. Rank hold ABCL as of Q2 2024.

State Board of Administration of Florida Retirement System reported no remaining AbCellera Biologics position as of Q2 2024 after selling out during the quarter.
State Board of Administration of Florida Retirement System sold 52,800 AbCellera Biologics shares in Q2 2024, an estimated $398K.
State Board of Administration of Florida Retirement System first reported a position in AbCellera Biologics in Q2 2022 and held it in 5 quarters.
State Board of Administration of Florida Retirement System's AbCellera Biologics position peaked at $547K in Q2 2022.
146 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2024.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2024, filed 8 Aug 2024.